|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-04
|
$2,507,598
|
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-05
|
$3,106,081
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Viruses and Cancer
|
5T32CA060395-22
|
$156,724
|
|
MEYERS, CRAIG
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program
|
5UG1CA189869-05
|
$1,196,666
|
|
GEYER, CHARLES
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-03
|
$386,051
|
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
5R01CA217625-02
|
$635,068
|
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
|
5R01CA210259-02
|
$667,691
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
5R01CA193220-04
|
$352,275
|
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
UBAP2, A New Molecule in Pancreatic Cancer Progression
|
1R01CA220237-01A1
|
$331,688
|
|
MUKHERJEE, PRIYABRATA
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission
|
5F31CA196329-03
|
$31,856
|
|
NASCIMENTO, ALDO
|
UNIVERSITY OF VIRGINIA
|
|
Tumor Suppressor Localization and Function at the Peroxisome
|
5R01CA143811-10
|
$356,625
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Tumor Cell Biology Training Program
|
5T32CA009056-42
|
$432,898
|
|
CROOKS, GAY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-04
|
$561,808
|
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Translation of a Clinical Molecular Diagnostic Assay for Bladder Cancer
|
5R01CA206584-02
|
$620,469
|
|
GOODISON, STEVE
|
MAYO CLINIC JACKSONVILLE
|
|
Transforming fluorescence lifetime imaging microscopy into a fast and simple platform for high-content molecular analysis
|
5R21CA206953-03
|
$221,650
|
|
HAUN, JERED
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Training providers in CBT plus Hypnosis - an evidence-based fatigue intervention
|
5R25CA193098-04
|
$295,813
|
|
MONTGOMERY, GUY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Training Program in Translational Brain Tumor Research
|
5T32CA151022-09
|
$510,532
|
|
COSTELLO, JOSEPH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Training Program in Cancer Biology
|
5T32CA078207-19
|
$554,252
|
|
AARONSON, STUART
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Training in Molecular& Genetic Epidemiology of Cancer
|
5R25CA112355-14
|
$525,610
|
|
WITTE, JOHN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling
|
5U01CA198900-04
|
$470,021
|
|
TSENG, HSIAN-RONG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Therapy for Metastatic breast cancer based on micro RNA silencing
|
1R01CA221771-01A1
|
$572,534
|
|
MEDAROVA, ZDRAVKA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Therapeutic Targeting of Malignant Glioma Stem Cells
|
5R35CA197725-05
|
$902,878
|
|
LESNIAK, MACIEJ
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
|
5R01CA148761-09
|
$431,667
|
|
PEROU, CHARLES
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Therapeutic Strategies for Patients With BRAF Mutant Colorectal Cancer
|
5R01CA187238-05
|
$332,000
|
|
HONG, DAVID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-10
|
$3,474,603
|
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The University of North Carolina Center for AIDS Research
|
5P30AI050410-21
|
$457,341
|
|
SWANSTROM, RONALD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis
|
5R00CA175181-05
|
$219,120
|
|
SKALSKY, REBECCA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
|
5R01CA219083-02
|
$368,288
|
|
MOON, EDMUND
|
UNIVERSITY OF PENNSYLVANIA
|
|
The role of The Xenopus Nonclassical MHC class I molecule XNC10 in Tumor Immunity
|
5F31CA192664-04
|
$42,497
|
|
BANACH, MAUREEN
|
UNIVERSITY OF ROCHESTER
|
|
The role of the PI3K pathway in immune resistance
|
5R01CA187076-05
|
$332,000
|
|
HWU, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The role of social media in social support acquisition for young adult informal cancer caregivers: A mixed-methods study
|
5F31CA221000-02
|
$39,884
|
|
WARNER, ECHO
|
UNIVERSITY OF UTAH
|
|
The Role of post-translational activation of Myc in pancreatic cancer
|
3R01CA196228-04S1
|
$100,339
|
|
SEARS, ROSALIE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The role of PLAG1 in Wilms tumor formation
|
5K08CA207849-02
|
$156,645
|
|
CHEN, KENNETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression
|
5R01CA196259-04
|
$396,302
|
|
DIGIOVANNI, JOHN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
The role of CHD5 in chromatin-mediated regulation of neural stem cells and glioma
|
5R01CA190997-05
|
$606,309
|
|
MILLS, ALEA
|
COLD SPRING HARBOR LABORATORY
|
|
The role of adipocytes in melanoma
|
5F32CA210536-02
|
$61,174
|
|
ZHANG, XIANG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
|
5U01CA198880-04
|
$586,386
|
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
The mTOR and Hippo pathway in cell growth and cancer
|
5R35CA196878-04
|
$912,964
|
|
GUAN, KUN-LIANG
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
The Impact of Maternal Obesity on the Reprogramming of the Metastatic Microenvironment
|
5K01CA218305-02
|
$103,375
|
|
HILLIARD, TYVETTE
|
UNIVERSITY OF NOTRE DAME
|
|
THE EPIGENETIC ROLE OF THE NOVEL LONG NONCODING RNA, LCAL5, IN LUNG CANCER
|
5R03CA215372-02
|
$76,250
|
|
WHITE, NICOLE
|
WASHINGTON UNIVERSITY
|
|
The cBioPortal for Cancer Genomics
|
5U24CA220457-02
|
$1,259,920
|
|
SCHULTZ, NIKOLAUS
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The adaptive kinome in pancreatic cancer
|
5R01CA193650-04
|
$593,093
|
|
YEH, JEN JEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-05
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Targeting the MLL complex in Castration Resistant Prostate Cancer
|
5R01CA200660-03
|
$378,124
|
|
GREMBECKA, JOLANTA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
5R01CA201124-03
|
$259,646
|
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Targeting telomerase for melanoma therapeutics
|
5R01CA201312-03
|
$471,448
|
|
SKORDALAKES, EMMANUEL
|
WISTAR INSTITUTE
|
|
Targeting protein-protein interactions of Bmi1 oncoprotein
|
5R01CA201204-03
|
$319,688
|
|
GREMBECKA, JOLANTA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeting of Genes in the Mammalian Genome
|
5R01CA210165-43
|
$468,711
|
|
CAPECCHI, MARIO
|
UNIVERSITY OF UTAH
|
|
Targeting novel DAMP mediated signaling pathways to mitigate GVHD
|
5R01CA217156-02
|
$429,228
|
|
REDDY, PAVAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
Total relevant funding to Herpes - Genital for this search: $96,963
|